Trial · NCT06808321
Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
NCT06808321, Completed, The Society of Prevention and Awareness of Cardiovascular Diseases
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients. Trials, record NCT06808321. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06808321
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
- NCT number
- NCT06808321
- Status
- Completed
- Enrollment
- 1,659 participants, actual
- Lead sponsor
- The Society of Prevention and Awareness of Cardiovascular Diseases
- Conditions
- Chronic Coronary Syndrome, Hypertension, Angina Pectoris
- Interventions
- Benidipine Hydrochloride
- First posted
- 2025-02-05
- Last updated
- 2026-11-04
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Systolic Blood Pressure at Month 3 | Baseline and Month 3 | Change in systolic blood pressure (SBP), measured in mmHg, from baseline to Month 3. The change is calculated as the SBP value at Month 3 minus the baseline SBP value (Month 3 SBP - Baseline SBP). Positive values indicate an increase in systolic blood pressure, whereas negative values indicate a decrease in systolic blood pressure. |
| Primary | Change From Baseline in Diastolic Blood Pressure at Month 3 | Baseline and Month 3 | Change in diastolic blood pressure (DBP), measured in mmHg, from baseline to Month 3. The change is calculated as the DBP value at Month 3 minus the baseline DBP value (Month 3 DBP - Baseline DBP). Positive values indicate an increase in diastolic blood pressure, whereas negative values indicate a decrease in diastolic blood pressure. |
| Primary | Change From Baseline in Seattle Angina Questionnaire Score at Month 3 | Baseline and Month 3 | The Seattle Angina Questionnaire (SAQ) is a disease-specific questionnaire used to assess health status in patients with coronary artery disease. The SAQ score ranges from 0 to 100, with higher scores indicating better angina-related health status. Change from baseline to Month 3 is calculated as the Month 3 score minus the baseline score. Positive values indicate an increase in the SAQ score, whereas negative values indicate a decrease in the SAQ score. |
| Secondary | Treatment Persistence and Patient Compliance at Month 3 | Baseline and Month 3 | Evaluation of the percentage of participants who continued their prescribed Benidipine treatment without interruption and adhered to the clinical follow-up protocol over a 3-month period. Persistence is defined as the continued use of the medication from baseline to the final visit. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06808321
GET https://conductscience.org/api/trials/v1/NCT06808321/registered